Fecal microbiota transplantation for clostridium difficile infection a systematic review

Annals of Internal Medicine

Volumn 162, Issue 9, 2015, Pages 630-638

  Drekonja, Dimitri ^a   Reich, Jon ^a   Gezahegn, Selome ^a   Greer, Nancy ^a   Shaukat, Aasma ^a   MacDonald, Roderick ^a   Rutks, Indy ^a   Wilt, Timothy J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ABDOMINAL PAIN; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTEREMIA; BIOLOGICAL THERAPY; BLOATING; CASE STUDY; CLOSTRIDIUM DIFFICILE INFECTION; COCHRANE LIBRARY; COLONOSCOPY; COMPARATIVE EFFECTIVENESS; DIARRHEA; DIZZINESS; ERUCTATION; FEASIBILITY STUDY; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FEVER; FOURNIER GANGRENE; GASTROENTERITIS; GASTROINTESTINAL HEMORRHAGE; HERPES ZOSTER; HUMAN; HYPOTENSION; INTESTINE; LAVAGE; MEDLINE; NASOGASTRIC TUBE; NAUSEA; PATIENT ATTITUDE; PERITONITIS; PNEUMONIA; PNEUMOPERITONEUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; STEM CELL TRANSPLANTATION; SYMPTOM; SYSTEMATIC REVIEW; TOXIC MEGACOLON; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTIONS; FECES; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; HUMANS; MICROBIOTA; RECURRENCE;

EID: 84928885767     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-2693     Document Type: Review

References (59)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxinproducing clostridia. N Engl J Med. 1978;298:531-4. [PMID: 625309]
2. Larson HE, Price AB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978;1: 1063-6. [PMID: 77366]
3. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis. 2011;11:194. [PMID: 21762504] doi:10.1186/1471-2334-11-194
4. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Accessed at www.cdc.gov /drugresistance/threat-report-2013 on 8 May 2014.
5. Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58:403-10. [PMID: 19394704] doi:10.1016/j.jinf.2009.03.010
6. Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, et al; OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422-31. [PMID: 21288078] doi:10.1056/NEJMoa0910812
7. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31:1012-7. [PMID: 11049785]
8. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97:1769-75. [PMID: 12135033]
9. Wilson KH. The microecology of Clostridium difficile. Clin Infect Dis. 1993;16 Suppl 4:S214-8. [PMID: 8324122]
10. Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014;48:693-702. [PMID: 24440934] doi:10.1097/MCG.0000000000000046
11. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368:407-15. [PMID: 23323867] doi:10.1056/NEJMoa1205037
12. Silverman MS, Davis I, Pillai DR. Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol. 2010;8:471-3. [PMID: 20117243] doi: 10.1016/j.cgh.2010.01.007
13. Debast SB, Bauer MP, Kuijper EJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20 Suppl 2:1-26. [PMID: 24118601] doi:10.1111/1469 -0691.12418
14. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108:478-98. [PMID: 23439232] doi:10.1038/ajg.2013.4
15. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9:1044-9. [PMID: 21871249] doi: 10.1016/j.cgh.2011.08.014
16. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions-Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63:513-23. [PMID: 19595577] doi:10.1016 /j.jclinepi.2009.03.009
17. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Accessed at www.cochrane-hand book.org on 6 October 2014.
18. Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58: 1515-22. [PMID: 24762631] doi:10.1093/cid/ciu135
19. Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312:1772-8. [PMID: 25322359] doi:10.1001/jama.2014.13875
20. Yoon SS, Brandt LJ. Treatment of refractory/recurrent C. difficile- associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol. 2010;44:562-6. [PMID: 20463588] doi:10.1097/MCG.0b013e3181dac035
21. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet. 1989;1:1156-60. [PMID: 2566734]
22. Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe. 2013;19:22-6. [PMID: 23182843] doi: 10.1016/j.anaerobe.2012.11.004
23. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol. 2010;44:567-70. [PMID: 20485184] doi: 10.1097/MCG.0b013e3181dadb10
24. Pathak R, Enuh HA, Patel A, Wickremesinghe P. Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation. Clin Exp Gastroenterol. 2013;7:1-6. [PMID: 24421645] doi:10.2147/CEG.S53410
25. Paterson DL, Iredell J, Whitby M. Putting back the bugs: bacterial treatment relieves chronic diarrhoea [Letter]. Med J Aust. 1994;160: 232-3. [PMID: 8309401]
26. Patel NC, Griesbach CL, DiBaise JK, Orenstein R. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc. 2013;88:799-805. [PMID: 23910407] doi:10.1016/j.mayocp.2013.04.022
27. Mellow MH, Kanatzar A. Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection-results and follow-up. J Okla State Med Assoc. 2011;104:89-91. [PMID: 21608450]
28. Mattila E, Uusitalo-Seppl R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology. 2012;142:490-6. [PMID: 22155369] doi:10.1053 /j.gastro.2011.11.037
29. MacConnachie AA, Fox R, Kennedy DR, Seaton RA. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM. 2009;102:781-4. [PMID: 19726581] doi:10.1093 /qjmed/hcp118
30. Khan MA, Sofi AA, Ahmad U, Alaradi O, Khan AR, Hammad T, et al. Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection. Can J Gastroenterol Hepatol. 2014;28:434-8. [PMID: 25014180]
31. Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol. 2012;46:145-9. [PMID: 22157239] doi:10.1097/MCG.0b013e318234570b
32. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:761-7. [PMID: 22290405] doi:10.1038/ajg.2011.482
33. Gustafsson A, Berstad A, Lund-Tnnesen S, Midtvedt T, Norin E. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol. 1999;34:580-6. [PMID: 10440607]
34. Garborg K, Waagsb B, Stallemo A, Matre J, Sund y A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis. 2010;42:857-61. [PMID: 20662620] doi:10.3109/00365548.2010.499541
35. Emanuelsson F, Claesson BE, Ljungstrm L, Tvede M, Ung KA. Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients. Scand J Infect Dis. 2014;46:89-97. [PMID: 24354958] doi: 10.3109/00365548.2013.858181
36. Dutta SK, Girotra M, Garg S, Dutta A, von Rosenvinge EC, Maddox C, et al. Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2014;12:1572-6. [PMID: 24440222] doi: 10.1016/j.cgh.2013.12.032
37. Cammarota G, Ianiro G, Gasbarrini A, Masucci L, Sanguinetti M. Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy [Letter]. Dig Liver Dis. 2014;46:475. [PMID: 24457126] doi:10.1016/j.dld.2013.12.011
38. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36:580-5. [PMID: 12594638]
39. Lee CH, Belanger JE, Kassam Z, Smieja M, Higgins D, Broukhanski G, et al. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis. 2014;33:1425-8. [PMID: 24627239] doi: 10.1007/s10096-014-2088-9
40. Zainah H, Hassan M, Shiekh-Sroujieh L, Hassan S, Alangaden G, Ramesh M. Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection. Dig Dis Sci. 2015;60:181-5. [PMID: 25052150] doi:10.1007/s10620- 014-3296-y
41. Weingarden AR, Hamilton MJ, Sadowsky MJ, Khoruts A. Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation [Letter]. J Clin Gastroenterol. 2013;47: 735-7. [PMID: 23632358] doi:10.1097/MCG.0b013e31829004ae
42. Bowden TA Jr, Mansberger AR Jr, Lykins LE. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg. 1981;47:178-83. [PMID: 7224366]
43. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854-9. [PMID: 13592638]
44. Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109:1065-71. [PMID: 24890442] doi:10.1038/ajg.2014.133
45. Solari PR, Fairchild PG, Noa LJ, Wallace MR. Tempered enthusiasm for fecal transplant [Letter]. Clin Infect Dis. 2014;59:319. [PMID: 24759832] doi:10.1093/cid/ciu278
46. Kleger A, Schnell J, Essig A, Wagner M, Bommer M, Seufferlein T, et al. Fecal transplant in refractory Clostridium difficile colitis. Dtsch Arztebl Int. 2013;110:108-15. [PMID: 23468820] doi:10.3238 /arztebl.2013.0108
47. Quera R, Espinoza R, Estay C, Rivera D. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection [Letter]. J Crohns Colitis. 2014;8:252-3. [PMID: 24184170] doi:10.1016/j.crohns.2013.10.002
48. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11:1036-8. [PMID: 23669309] doi:10.1016/j.cgh.2013.04.045
49. Schwartz M, Gluck M, Koon S. Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts [Letter]. Am J Gastroenterol. 2013;108:1367. [PMID: 23912408] doi: 10.1038/ajg.2013.164
50. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107:1079-87. [PMID: 22450732] doi:10.1038/ajg.2012.60
51. Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis. 2007;44:846-8. [PMID: 17304459]
52. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol. 1985;80:867-8. [PMID: 4050760]
53. Moore TA, Rodriguez A, Bakken JS. Reply to Solari et al [Letter]. Clin Infect Dis. 2014;59:319-20. [PMID: 24759828] doi:10.1093/cid /ciu279
54. Lund-T nnesen S, Berstad A, Schreiner A, Midtvedt T. [Clostridium difficile-associated diarrhea treated with homologous feces]. Tidsskr Nor Laegeforen. 1998;118:1027-30. [PMID: 9531822]
55. Nieuwdorp M, van Nood E, Speelman P, van Heukelem HA, Jansen JM, Visser CE, et al. [Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Ned Tijdschr Geneeskd. 2008;152:1927-32. [PMID: 18808083]
56. Polk P, Freibergerov M, Jur nkov J, Kocourkov H, Mikešov L, Svacina R, et al. [First experiences with faecal bacteriotherapy in the treatment of relapsing pseudomembranous colitis due to Clostridium difficile]. Klin Mikrobiol Infekc Lek. 2011;17:214-7. [PMID: 22247032]
57. Sihvonen R, Paavola M, Malmivaara A, It l A, Joukainen A, Nurmi H, et al; Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med. 2013;369:2515-24. [PMID: 24369076] doi:10.1056/NEJMoa1305189
58. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014; 370:1393-401. [PMID: 24678939] doi:10.1056/NEJMoa1402670
59. Redberg RF. Sham controls in medical device trials. N Engl J Med. 2014;371:892-3. [PMID: 25184861] doi:10.1056/NEJMp 1406388